Skip to content

Clinical trials

Completed Observational Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Observational Status: Completed Clear all

297 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20027
20036
200413
200512
200612
200723
200816
200927
201018
201116
201216
201317
201412
20159
20168
20177
20189
20198
20207
20218
202211
20235
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed297

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca40
National Institute of Mental Health (NIMH)15
National Institute on Drug Abuse (NIDA)11
National Taiwan University Hospital8
University of Maryland, Baltimore8
Janssen-Cilag, S.A.6
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5
Seoul National University Hospital5
Janssen-Cilag International NV4
Shanghai Mental Health Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia297
Psychotic Disorders60
Bipolar Disorder49
Mental Disorders20
Major Depressive Disorder10
Substance-Related Disorders8
Depressive Disorder7
Anxiety Disorders6
Diabetes Mellitus6
Metabolic Syndrome6

Trials

Showing 1 to 25 of 297. Each trial links to its page on Pharma Observatory.

197 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.